Winton Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-291,360
| Closed | – | – | 1563 |
|
|
2021
Q3 | $0 | Hold |
291,360
| – | – | ﹤0.01% | 1538 |
|
|
2021
Q2 | $0 | Hold |
291,360
| – | – | ﹤0.01% | 1568 |
|
|
2021
Q1 | $0 | Hold |
291,360
| – | – | ﹤0.01% | 1493 |
|
|
2020
Q4 | $720K | Sell |
291,360
-283,063
| -49% | -$699K | 0.05% | 594 |
|
|
2020
Q3 | $1.81M | Sell |
574,423
-268,527
| -32% | -$846K | 0.06% | 572 |
|
|
2020
Q2 | $2.45M | Buy |
842,950
+205,639
| +32% | +$598K | 0.06% | 551 |
|
|
2020
Q1 | $1.8M | Sell |
637,311
-1,306,463
| -67% | -$3.68M | 0.05% | 607 |
|
|
2019
Q4 | $6.31M | Buy |
1,943,774
+369,994
| +24% | +$1.2M | 0.09% | 396 |
|
|
2019
Q3 | $3.4M | Buy |
1,573,780
+186,895
| +13% | +$404K | 0.04% | 409 |
|
|
2019
Q2 | $4.36M | Buy |
1,386,885
+51,942
| +4% | +$163K | 0.08% | 222 |
|
|
2019
Q1 | $4.97M | Buy |
+1,334,943
| New | +$4.97M | 0.1% | 245 |
|